Cite
HARVARD Citation
Latif, F. et al. (2022). Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis. Expert review of anticancer therapy. 22 (2), pp. 229-235. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Latif, F. et al. (2022). Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis. Expert review of anticancer therapy. 22 (2), pp. 229-235. [Online].